Philip D. Ross - Concepedia

Author

Philip D. Ross

Bone Health and Osteoporosis Foundation

Also Known As

P D Ross, P Ross, P. D. ROSS, P. D. Ross, P. Ross, P.D Ross, P.D. Ross, PHILIP D ROSS, PHILIP D. ROSS, PHILIP D. Ross

272

Publications

26.1K

Citations

H-Index

236

Concepts

All Affiliations

Bone Health and Osteoporosis Foundation Merck & Co., Inc., Rahway, NJ, USA (United States)National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute of Diabetes and Digestive and Kidney Diseases

About

Philip D. Ross is an author at Bone Health and Osteoporosis Foundation specializing in medicine, osteoporosis, and bone health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	23	26	2.2K
2	Engineering	21	29	1.5K
3	Education	3	3	387
4	Arts	1	1	190
5	Language Studies	1	1	211

Philip D. Ross

173

Publications

23.8K

Citations

H-Index

Page 1

	Year	Citations
Thermodynamics of protein association reactions: forces contributing to stability Philip D. Ross, Sankaran Subramanian Biochemistry Altmetric Attention ScoreMolecular BiologyBibliometricsAltmetricsProtein Folding	1981	5.4K
Patients with Prior Fractures Have an Increased Risk of Future Fractures: A Summary of the Literature and Statistical Synthesis Carolyn M. Klotzbuecher, Philip D. Ross, Pamela B. Landsman, Journal of Bone and Mineral Research Prior FracturesBone DiseaseSkeletal TraumaBone HealthPrior Fracture	2000	2K
Pre-Existing Fractures and Bone Mass Predict Vertebral Fracture Incidence in Women Philip D. Ross, James W. Davis, Robert S. Epstein, Annals of Internal Medicine	1991	1.1K
Intermittent Cyclical Etidronate Treatment of Postmenopausal Osteoporosis Nelson B. Watts, Steven T. Harris, Harry K. Genant, New England Journal of Medicine	1990	956
Kinetics and Mechanism of Deoxyhemoglobin S Gelation: A New Approach to Understanding Sickle Cell Disease James Hofrichter, Philip D. Ross, William A. Eaton Proceedings of the National Academy of Sciences	1974	503
Prevention of Bone Loss with Alendronate in Postmenopausal Women under 60 Years of Age David Hosking, Clair E.D. Chilvers, Claus Christiansen, New England Journal of Medicine	1998	487
Predicting vertebral fracture incidence from prevalent fractures and bone density among non-black, osteoporotic women Philip D. Ross, Harry K. Genant, James W. Davis, Osteoporosis International Bone DiseaseSkeletal TraumaBone HealthBiostatisticsVertebral Fracture Incidence	1993	369
Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: Three years of blinded therapy followed by one year of open therapy Steven T. Harris, Nelson B. Watts, Rebecca D. Jackson, The American Journal of Medicine Bone DiseaseBone HealthOpen TherapyOsteopathyBlinded Therapy	1993	355
Skeletal Benefits of Alendronate: 7-Year Treatment of Postmenopausal Osteoporotic Women<sup>1</sup> Richard P. Tonino, Pierre J. Meunier, Ronald Emkey, The Journal of Clinical Endocrinology & Metabolism GynecologyPharmacotherapyOsteoporosisOrthopaedic SurgeryBone Disease	2000	337
Prediction of postmenopausal fracture risk with use of bone mineral measurements Richard D. Wasnich, Philip D. Ross, Lance K. Heilbrun, American Journal of Obstetrics and Gynecology Bone DiseaseSkeletal TraumaBone HealthMedicineBiostatistics	1985	332

Page 1